Refractory precursor T-lymphoblastic lymphoma/leukemia
MONDO:0004404T-lymphoblastic leukemia/lymphoma resistant to treatment
Also known as: precursor T lymphoblastic lymphoma/leukemia refractory, refractory T lymphoblastic leukemia/lymphoma, refractory precursor T-lymphoblastic lymphoma/leukemia
1882 clinical trials for this condition and its sub-types, 31 tagged with Refractory precursor T-lymphoblastic lymphoma/leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug combo tested for tough childhood leukemia
Disease control CompletedThis early-phase study tested whether adding the targeted drug palbociclib to standard chemotherapy is safe for children with acute lymphoblastic leukemia that has returned or not responded to treatment. Only 2 children took part, and the main goal was to find the highest tolerab…
Phase 1 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New antibody drug tested in patients with relapsed blood cancers
Disease control CompletedThis early-stage trial tested the safety and best dose of flotetuzumab, an antibody drug, in 13 patients with advanced blood cancers that had come back or stopped responding to treatment. The drug works by blocking cancer cell growth. The main goal was to see what side effects oc…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC